Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00234
http://purl.obolibrary.org/obo/dinto_DB00234
|
|---|---|
| Preferred Name | reboxetine |
| Synonyms |
C19H23NO3
(2S)-2-[(S)-2-ethoxyphenoxy(phenyl)methyl]morpholine
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | reboxetine
|
|---|---|
| label | reboxetine
|
| DBSynonym | reboxetine mesylate
|
| ATCCode | N06AX18
|
| Definition | Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine.
|
| has pharmacological target | |
| induces | |
| inhibits | |
| type | |
| InChIKey | InChIKey=CBQGYUDMJHNJBX-OALUTQOASA-N
|
| is metabolised by | |
| Synonym |
C19H23NO3
(2S)-2-[(S)-2-ethoxyphenoxy(phenyl)methyl]morpholine
|
| xref |
PubChem Substance:46504845
PubChem Compound:65856
BindingDB:35226
ChemSpider:59268
Wikipedia:http://en.wikipedia.org/wiki/Reboxetine
PharmGKB:PA144614921
See more
See less
|
| CASRN | 98769-81-4
|
| prefixIRI | obo2:dinto_DB00234
|
| SMILES | [H][C@]1(CNCCO1)[C@@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1
|
| InChI | InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1
|
| DBBrand |
davedax
edronax
prolift
solvex
vestra
norebox
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |